Concepedia

Spencer Drummond

SD

Statistics

Publications

7

Citations

257

H-Index

7

Active since

1992

Affiliations

DuPont (United States)(Current)

Wilmington University

Experimental Station

Bristol-Myers Squibb (United States)

Spencer Drummond is an author at DuPont (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1992–2006

7

Publications

7

Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-<i>N</i>- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1<i>H</i>-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor

James R. Pruitt, Donald Pinto, Robert A. Galemmo et al. · Journal of Medicinal Chemistry · 2003 · 75 citations · Full text

, , +15

Novel piperidine .sigma. receptor ligands as potential antipsychotic drugs

Paul J. Gilligan, Gary A. Cain, Thomas E. Christos et al. · Journal of Medicinal Chemistry · 1992 · 66 citations · Full text

, , +17

Singlet oxygen oxidation of pyrroles: Synthesis and chemical transformations of novel 4,4-bis(trifluoromethyl)imidazoline analogs

Hui-Yin Li, Spencer Drummond, Indawati DeLucca et al. · Tetrahedron · 1996 · 55 citations

, , +11

Pyrazole-based factor Xa inhibitors containing N-arylpiperidinyl P4 residues

Jennifer X. Qiao, Xuhong Cheng, Joanne M. Smallheer et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 19 citations · Full text

, , +10

An Unusual Trifluoromethyl Elimination Reaction from the 4,4-Bis(trifluoromethyl)-5-hydroxyimidazoline Ring System

Hui-Yin Li, Indawati DeLucca, Spencer Drummond et al. · The Journal of Organic Chemistry · 1997 · 17 citations

, , +8

1–5 of 7